noratropine: RN given refers to endo-(+-)-isomer
ID Source | ID |
---|---|
PubMed CID | 12442859 |
SCHEMBL ID | 4524264 |
SCHEMBL ID | 19236051 |
MeSH ID | M0115821 |
Synonym |
---|
norhyoscyamine |
noratropine |
16839-98-8 |
benzeneacetic acid, alpha-(hydroxymethyl)-, 8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)- |
sn61db9ow3 , |
unii-sn61db9ow3 |
benzeneacetic acid, .alpha.-(hydroxymethyl)-, (3-endo)-8-azabicyclo(3.2.1)oct-3-yl ester |
benzeneacetic acid, .alpha.-(hydroxymethyl)-, 8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+/-)- |
benzeneacetic acid, .alpha.-(hydroxymethyl)-, 8-azabicyclo(3.2.1)oct-3-yl ester, endo- |
atropine sulfate impurity b [ep impurity] |
(1r,3r,5s)-8-azabicyclo(3.2.1)oct-3-yl (2rs)-3-hydroxy-2-phenylpropanoate |
1.alpha.h,5.alpha.h-nortropan-3.alpha.-ol, (+/-)-tropate (ester) |
SCHEMBL4524264 |
SCHEMBL19236051 |
(1r,3r,5s)-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate |
mfcd22666261 |
noratropin |
Q27289292 |
[(1r,5s)-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate |
AKOS040753307 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (30.88) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |